News Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse Other stock markets 01:30:02 04/05/2024 am IST			5-day change	1st Jan Change
19.61 ^USD	+0.56%		+5.71%	+35.99%

02/05	Organon's Q1 Adjusted Earnings, Revenue Rise; 2024 Revenue Guidance, Quarterly Dividend Maintained	MT
02/05	Transcript : Organon & Co., Q1 2024 Earnings Call, May 02, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Organon : Q1 2024 Transcript	03/05	PU
Organon's Q1 Adjusted Earnings, Revenue Rise; 2024 Revenue Guidance, Quarterly Dividend Maintained	02/05	MT
Organon : Q1 2024 Earnings Presentation	02/05	PU
Organon : 2024 Annual Meeting of Shareholders	02/05	PU
Transcript : Organon & Co., Q1 2024 Earnings Call, May 02, 2024	02/05
Earnings Flash (OGN) ORGANON & CO. Reports Q1 Revenue $1.62B, vs. Street Est of $1.56B	02/05	MT
Organon: Q1 Earnings Snapshot	02/05	AQ
Earnings Flash (OGN) ORGANON & CO. Reports Q1 EPS $1.22, vs. Street Est of $0.93	02/05	MT
Organon Reports Results for the First Quarter Ended March 31, 2024	02/05	BU
Organon & Co. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05	CI
Organon & Co. Provides Earnings Guidance for the Year 2023	02/05	CI
Organon & Co Declares Quarterly Dividend on Common Stock, Payable on June 13, 2024	02/05	CI
Piper Sandler Raiises Price Target on Organon to $24 From $22, Maintains Overweight Rating	29/04	MT
Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating	09/04	MT
Shanghai Henlius Biotech Denosumab Biosimilar HLX14 Meets Endpoint	08/04	MT
Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024	08/04	BU
Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints	08/04	BU
Aurobindo Pharma Gets US FDA Final Nod for Mometasone Furoate Monohydrate Nasal Spray	20/03	MT
On International Women's Day, Organon Canada is encouraging businesses to Invest in HER and help address gender inequities through women's health	08/03	AQ
Philips: new CFO in October	28/02	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Organon & Co.

Equities

OGN

US68622V1061

Summary

Filters